Navigation Links
2 studies examine medical consequences of police use of force during restraint
Date:5/16/2009

Dr. Jared Strote at the University of Washington Medical Center led a group that examined the medical records of nearly 900 patients subdued by the Seattle Police Department with a Taser over a six-year period. Less than one percent required hospital admission for an injury related to the restraint incident. No deaths occurred, even when patients exhibited signs of excited delirium.

Meanwhile, a separate study led by Dr. Strote looked at every use of force by the Seattle Police Department in one year. Again, despite nearly 900 incidents, injuries related to the use of force were rare. Just over one percent required hospital admission for an injury related to the use of force by police. There were two deaths, both due to firearms.

The researchers conclude that injuries inflicted by police officers in the process of subduing suspects are relatively rare. Other related findings include a high incidence of drug and alcohol use and psychiatric history among those being restrained.


'/>"/>

Contact: Sean Wagner
swagner@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1

Related medicine news :

1. Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
2. Studies show LAM patients participate in clinical trials to help others, not themselves
3. Traumatic brain injury haunts children for years with variety of functional problems: Two studies
4. Review finds conflicts of interest in many cancer studies
5. Studies Report Use of USGI Medicals Incisionless Operating Platform(TM) (IOP) in Numerous Incisionless Surgical Procedures
6. Physicians Conduct Research Studies in Minutes, Not Months, at Montefiore Medical Center
7. Kessler Foundation Research Center Presented Two Studies on Post-stroke Spatial Neglect at American Academy of Neurology
8. Studies uncover high and often overlooked costs associated with epilepsy
9. Are we cherry picking participants for studies of antidepressants?
10. Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas
11. Pharos Innovations and Clients to Showcase Three Client Case Studies at Upcoming ATA Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 28, 2017 , ... Semrock’s highly popular SearchLight Spectra Viewer ... resource for fluorescence microscopists and optical system designers, enabling The Right Solution, Right ... the globe, SearchLight has become a tremendously popular tool for the fluorescence imaging ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of its ... times purer and more potent than the market has seen before. Swissx uses proprietary ... well as a patented chromatography process for extraction, to produce its CBD oil--maximizing its ...
(Date:4/26/2017)... , ... April 26, 2017 , ... Journal of ... It can have severe consequences to overall dental health, including complications with speech, eating, ... turn to dental implants to replace lost teeth. As the number of tooth replacements ...
(Date:4/26/2017)... ... April 26, 2017 , ... The ... Excellence upon National Registry of Emergency Medical Technicians and welcomes this ... said Dr. Jan G. West, Ph.D. , CEO & Organizational Psychologist at ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... England , April 24, 2017 ... development, today announced the addition of a major ... ,Validated In-situ Plate Seeding,). The VIPS has been ... and 384 well microplates as part of the ... system offers a simple and more reliable solution ...
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: